An Open-label Extension Safety Study of MELAS Patients Who Completed TIS6463-203 (PRIZM)

Clinical trial NCT06961344 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06961344
Sponsor: Tisento Therapeutics
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Mitochondrial Encephalopathy, Lactic Acidosis and Stroke-Like Episodes (MELAS Syndrome)

Start date: 2025-08-18
Primary completion: 2028-07-01
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.